<https://rdf.molmedb.upol.cz/reference/ref1278> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target3>;
	<http://purl.org/ontology/bibo/doi> "10.1016/s0014-2999(01)00962-1"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17206>,
		<https://rdf.molmedb.upol.cz/transporter/target97>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17336>;
	<http://purl.org/ontology/bibo/pmid> "11426832"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H.: Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol, Volume 419 (2-3), 2001"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra31485> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1278> .
<https://rdf.molmedb.upol.cz/transporter/tra31655> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1278> .
<https://rdf.molmedb.upol.cz/transporter/tra31486> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1278> .